Blum HoldingsBLMH -3.98%14 EBITDA Margin % is -26.35% as of Sep. 2025. GuruFocus rates BLMH with a GF Score™ of 14/100 and a GF Value™ of $0.44 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Blum Holdings ranks better than 98.95% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Blum Holdings's EBITDA for the
three
months ended in Sep. 2025 was $-1.28 Mil. Blum Holdings's Revenue for the
three
months ended in Sep. 2025 was $4.85 Mil. Therefore, Blum Holdings's EBITDA margin for the quarter that ended in Sep. 2025 was -26.35%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Blum Holdings EBITDA Margin % Related Terms
Blum Holdings EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Blum Holdings's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BLMH vs HEWA, WGRX, DHTI: EBITDA Margin % Comparison
For the Pharmaceutical Retailers subindustry, Blum Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Blum Holdings EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Blum Holdings's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Blum Holdings's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Blum Holdings (BLMH) has a EBITDA Margin % of -26.35% as of Sep. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Blum Holdings and its competitors. According to the industry distribution chart, Blum Holdings ranks #7 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 1%.
Is Blum Holdings' EBITDA Margin % too high?
Blum Holdings' current EBITDA Margin % is -26.35%. Based on the distribution chart, Blum Holdings ranks #7 out of 668 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Blum Holdings has a GF Score™ of 14/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Blum Holdings' EBITDA Margin % compare to HEWA and WGRX?
According to the Healthcare Providers & Services industry distribution chart, Blum Holdings ranks #7 out of 668 companies for EBITDA Margin %. This places Blum Holdings in the top 1% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 10.21. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Blum Holdings and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Blum Holdings's current EBITDA Margin % is -26.35%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Blum Holdings stock overvalued right now?
Based on GuruFocus' analysis, Blum Holdings (BLMH) is currently considered Possible Value Trap. The stock's GF Value™ is $0.44, compared to a current price of $0.19 — trading 56.1% below its estimated fair value. The current EBITDA Margin % is -26.35%. Blum Holdings' overall GF Score™ is 14/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Blum Holdings (BLMH), the current EBITDA Margin % is -26.35% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Blum Holdings (BLMH) Overvalued in 2026?
Based on GuruFocus' analysis, Blum Holdings stock appears to be undervalued.
The current stock price of $0.19 is trading 56.1% below its estimated GF Value™ of $0.44.
GuruFocus considers Blum Holdings to be Possible Value Trap.
Key valuation signals for BLMH:
EBITDA Margin %: -26.35%
GF Value™: $0.44 vs. price of $0.19 (56.1% below fair value)
No single metric tells the full story. See the BLMH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Blum Holdings Inc is a cannabis company with operations in retail, production, distribution, and cultivation, with an emphasis on providing the highest quality of medical and adult-use cannabis products. It distributes its own branded products as well as third-party products to its retail dispensaries in California under the Korova brand. The company has two reportable segments; Cannabis Retail which generates key revenue and includes cannabis-focused retail, both physical stores and non-store front delivery, and Cannabis Distribution segment which includes cannabis distribution operations.
14GF Score
Get the complete analysis for BLMH
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BLMH has been successfully added to your 
